Published Sep 25, 2026, 1:43 AM ET · Updated 2 months ago · 2 sources
Novo Signs Delivery Deal With Nanexa Worth Up to $1.3 Billion
bloomberg
·
Original Report
Novo Nordisk A/S signed a deal worth as much as €1.165 billion ($1.3 billion) with Sweden’s Nanexa AB for rights to its drug delivery technology for obesity and diabetes treatments.